0001950047-24-005238.txt : 20240703
0001950047-24-005238.hdr.sgml : 20240703
20240703131854
ACCESSION NUMBER: 0001950047-24-005238
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240703
DATE AS OF CHANGE: 20240703
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 562020050
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 241099239
BUSINESS ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (619) 949-3681
MAIL ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20150820
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: USMAN NASSIM
CENTRAL INDEX KEY: 0001206872
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
144
1
primary_doc.xml
144
0001206872
XXXXXXXX
LIVE
0001124105
Gyre Therapeutics Inc.
000-51173
12770 High Bluff Drive
Suite 150
San Diego
CA
92130
(858) 567-7770
NASSIM USMAN
Director
Common
Morgan Stanley Smith Barney LLC Executive Financial Services
1 New York Plaza
8th Floor
New York
NY
10004
33
396.00
85510116
07/03/2024
NASDAQ
Common
07/03/2024
Stock Option Exercise
Issuer
N
33
07/03/2024
Cash
N
NASSIM USMAN
12770 High Bluff Drive
Suite 150
San Diego
CA
92130
Common
07/02/2024
7767
93992.35
NASSIM USMAN
12770 High Bluff Drive
Suite 150
San Diego
CA
92130
Common
07/01/2024
12200
148098.24
NASSIM USMAN
12770 High Bluff Drive
Suite 150
San Diego
CA
92130
Common
06/28/2024
3452
41437.12
NASSIM USMAN
12770 High Bluff Drive
Suite 150
San Diego
CA
92130
Common
05/01/2024
20000
282472.00
07/03/2024
12/12/2023
/s/ Nassim Usman